Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

AGA treated with finasteride, minoxidil, and hair transplantation.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

Increased PPARGC1α relates to hair thinning in common baldness.

Hair thickness differences help diagnose hair loss severity.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

STEAP3 protein might help treat hair loss, but more testing is needed.

Only anti-androgenic drugs likely halt AGA progression.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Alkaline phosphatase activity decreases in early alopecia areata.

Apoptosis may contribute to hair loss in androgenetic alopecia.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

Chinese medicine may help treat hair loss by affecting genes and enzyme activity.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

PRP can help treat hair loss but needs standardized methods for best results.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Caffeine may help hair growth in hereditary hair loss.

The peach gene pCTG134 helps control the interaction between auxin and ethylene hormones during fruit ripening.

Platelet Rich Plasma (PRP) therapy can improve hair thinning in male pattern baldness patients, but more research is needed to confirm its effectiveness.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

PRP, especially AA-PRP, can help improve hair growth in androgenetic alopecia.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.